Loading chat...
CT HB05791
Bill
Status
Introduced
1/21/2011
Primary Sponsor
Daniel Carter
Click for details
AI Summary
- Amends section 20-619 of the general statutes to require pharmacists to notify patients when a prescription drug manufacturer changes
- Notification requirement applies to both brand name and generic prescription medications
- Intended to ensure patients receive critical information about changes to their medications
- Referred to the Committee on Public Health
- Introduced by Rep. Carter of the 2nd District during the January 2011 session
Legislative Description
An Act Concerning The Duty Of A Pharmacist To Notify A Patient When The Manufacturer Of A Prescription Drug Is Changed.
Last Action
Referred to Joint Committee on Public Health
1/21/2011
Committee Referrals
Public Health1/21/2011
Full Bill Text
No bill text available